MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from exercise of
stock options
$704K
Net cash provided by
financing activities
$641K
Canceled cashflow
$63K
Net change in cash,
cash equivalents and...
-$5,204K
Canceled cashflow
$641K
Change in fair value of
the convertible...
$101,062K
Non-cash interest
expense
$5,555K
Stock-based compensation
expense
$1,075K
Prepaid expenses and
other assets
-$948K
Accrued compensation
$624K
Change in right-of-use
asset
-$516K
Depreciation expense
$457K
Payments for taxes
related to net share...
$63K
Net cash used in
operating activities
-$5,782K
Canceled cashflow
$110,237K
Net cash used in
investing activities
-$63K
Net loss
-$115,346K
Accounts payable and
accrued liabilities
-$352K
Operating lease liability
-$321K
Purchases of property and
equipment
$63K
Back
Back
Cash Flow
source: myfinsight.com
Armata Pharmaceuticals, Inc. (ARMP)
Armata Pharmaceuticals, Inc. (ARMP)